{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T23:29:34Z","timestamp":1773790174057,"version":"3.50.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10787-026-02150-4","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T04:36:10Z","timestamp":1771302970000},"page":"1529-1537","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ganaxolone as a promising therapeutic agent for Alzheimer\u2019s disease: signaling pathways and mechanistic insights\u2014a narrative review"],"prefix":"10.1007","volume":"34","author":[{"given":"Ankita","family":"Koundal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitish","family":"Chodhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himanshu","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanika","family":"Vashisht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahendra Singh","family":"Ashawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiv Kumar","family":"Kushawaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"issue":"15","key":"2150_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157502","volume":"26","author":"RS Alshehri","year":"2025","unstructured":"Alshehri RS, Alrawaili MS, Zawawi BM, Alzahrany M, Habib AH (2025) Pathophysiology of status epilepticus revisited. Int J Mol Sci 26(15):7502. https:\/\/doi.org\/10.3390\/ijms26157502","journal-title":"Int J Mol Sci"},{"key":"2150_CR2","doi-asserted-by":"publisher","first-page":"9545","DOI":"10.1007\/s12035-025-04844-2","volume":"62","author":"SS Alves","year":"2025","unstructured":"Alves SS et al (2025) Metformin improves spatial memory and reduces seizure severity in a rat model of epilepsy and Alzheimer\u2019s disease comorbidity via PI3K\/Akt signaling pathway. Mol Neurobiol 62:9545\u20139572. https:\/\/doi.org\/10.1007\/s12035-025-04844-2","journal-title":"Mol Neurobiol"},{"issue":"5","key":"2150_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/life14050582","volume":"14","author":"I Balan","year":"2024","unstructured":"Balan I, Boero G, Ch\u00e9ry SL, McFarland MH, Lopez AG, Morrow AL (2024) Neuroactive steroids, toll-like receptors, and neuroimmune regulation: insights into their impact on neuropsychiatric disorders. Life 14(5):582. https:\/\/doi.org\/10.3390\/life14050582","journal-title":"Life"},{"issue":"11","key":"2150_CR4","first-page":"5769","volume":"37","author":"S Bano","year":"2023","unstructured":"Bano S, Raza MA, Ghosh S, Pandit NS, Srivastava S, Azam M, Ruwali M (2023) Emerging therapeutic targets in molecular neuropharmacology for Alzheimer\u2019s disease. J Biol Regul Homeost Agents 37(11):5769\u20135784","journal-title":"J Biol Regul Homeost Agents"},{"key":"2150_CR5","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1007\/s10072-025-08023-y","volume":"46","author":"V Bhatia","year":"2025","unstructured":"Bhatia V, Chandel A, Minhas Y, Kushawaha SK (2025) Advances in biomarker discovery and diagnostics for Alzheimer\u2019s disease. Neurol Sci 46:2419\u20132436. https:\/\/doi.org\/10.1007\/s10072-025-08023-y","journal-title":"Neurol Sci"},{"issue":"4","key":"2150_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrendo.2013.31","volume":"9","author":"RD Brinton","year":"2013","unstructured":"Brinton RD (2013) Neurosteroids as regenerative agents in the brain: therapeutic implications. Nat Rev Endocrinol 9(4):241\u2013250. https:\/\/doi.org\/10.1038\/nrendo.2013.31","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"2150_CR7","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3233\/JAD-170543","volume":"62","author":"DA Butterfield","year":"2018","unstructured":"Butterfield DA, Boyd-Kimball D (2018) Oxidative stress, amyloid-\u03b2 peptide, and altered key molecular pathways in the pathogenesis and progression of Alzheimer\u2019s disease. J Alzheimers Dis 62(3):1345\u20131367. https:\/\/doi.org\/10.3233\/JAD-170543","journal-title":"J Alzheimers Dis"},{"key":"2150_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.612083","volume":"12","author":"T Cao","year":"2021","unstructured":"Cao T et al (2021) A potential mechanism underlying the therapeutic effects of progesterone and allopregnanolone on ketamine induced cognitive deficits. Front Pharmacol 12:612083. https:\/\/doi.org\/10.3389\/fphar.2021.612083","journal-title":"Front Pharmacol"},{"key":"2150_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177558","volume":"996","author":"D Chauhan","year":"2025","unstructured":"Chauhan D, Bagri K, Deshmukh R (2025) Neuroprotective effect of Perillyl alcohol in sporadic Alzheimer\u2019s disease in rats. Eur J Pharmacol 996:177558. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177558","journal-title":"Eur J Pharmacol"},{"key":"2150_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024293","volume":"6","author":"S Chen","year":"2011","unstructured":"Chen S, Wang JM, Irwin RW, Yao J, Liu L, Brinton RD (2011) Allopregnanolone promotes regeneration and reduces \u03b2-amyloid burden in a preclinical model of Alzheimer\u2019s disease. PLoS ONE 6:e24293. https:\/\/doi.org\/10.1371\/journal.pone.0024293","journal-title":"PLoS ONE"},{"issue":"6","key":"2150_CR11","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1002\/jnr.24821","volume":"99","author":"W Chen","year":"2021","unstructured":"Chen W, Santos P, Kulikowicz E, Koehler RC, Lee JK, Martin LJ (2021) Targeting the mitochondrial permeability transition pore for neuroprotection in a piglet model of neonatal hypoxic-ischemic encephalopathy. J Neurosci Res 99(6):1550\u20131564. https:\/\/doi.org\/10.1002\/jnr.24821","journal-title":"J Neurosci Res"},{"issue":"2","key":"2150_CR12","doi-asserted-by":"publisher","DOI":"10.15190\/d.2025.7","volume":"13","author":"S Chowdhury","year":"2025","unstructured":"Chowdhury S, Chowdhury S (2025) Novel medication Ganaxolone for seizure disorders. Discoveries 13(2):e208. https:\/\/doi.org\/10.15190\/d.2025.7","journal-title":"Discoveries"},{"issue":"4","key":"2150_CR13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.2174\/0929867330666230320123952","volume":"31","author":"SK De","year":"2024","unstructured":"De SK (2024) Ganaxolone: first FDA-approved medicine for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder. Curr Med Chem 31(4):388\u2013392. https:\/\/doi.org\/10.2174\/0929867330666230320123952","journal-title":"Curr Med Chem"},{"issue":"4","key":"2150_CR14","doi-asserted-by":"publisher","first-page":"7602","DOI":"10.4088\/JCP.19m12887","volume":"81","author":"Dichtel","year":"2020","unstructured":"Dichtel et al (2020) Effects of open-label, adjunctive ganaxolone on persistent depression despite adequate antidepressant treatment in postmenopausal women: a pilot study. J Clin Psychiatry 81(4):7602. https:\/\/doi.org\/10.4088\/JCP.19m12887","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"2150_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.26332\/seemedj.v1i1.26","volume":"1","author":"D \u0110iki\u0107","year":"2017","unstructured":"\u0110iki\u0107 D, Jutri\u0107 D, Dominko K (2017) The dual nature of the antiepileptic drug valproic acid, with possible beneficial effects in Alzheimer\u2019s disease. Southeast Eur Med J 1(1):74\u201389. https:\/\/doi.org\/10.26332\/seemedj.v1i1.26","journal-title":"Southeast Eur Med J"},{"issue":"2","key":"2150_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.70007","volume":"169","author":"FM Divya","year":"2025","unstructured":"Divya FM, Nazir SS, Kaushik P, Parvez S, Vohora D (2025) Ganaxolone reverses the effect of amyloid \u03b2-induced neurotoxicity by regulating the liver X receptor expression in APP-transfected SH-SY5Y cells and murine model of Alzheimer\u2019s disease. J Neurochem 169(2):e70007. https:\/\/doi.org\/10.1111\/jnc.70007","journal-title":"J Neurochem"},{"issue":"2","key":"2150_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ph11020044","volume":"11","author":"F Dur\u00e3es","year":"2018","unstructured":"Dur\u00e3es F, Pinto M, Sousa E (2018) Old drugs as new treatments for neurodegenerative diseases. Pharmaceuticals (Basel) 11(2):44. https:\/\/doi.org\/10.3390\/ph11020044","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"2150_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11011-025-01631-9","volume":"40","author":"Ebrahimi","year":"2025","unstructured":"Ebrahimi et al (2025) Microglial activation as a hallmark of neuroinflammation in Alzheimer\u2019s disease. Metab Brain Dis 40(5):207. https:\/\/doi.org\/10.1007\/s11011-025-01631-9","journal-title":"Metab Brain Dis"},{"issue":"7","key":"2150_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ph18070945","volume":"18","author":"TA Fedotcheva","year":"2025","unstructured":"Fedotcheva TA, Shimanovsky NL (2025) Neurosteroids progesterone and dehydroepiandrosterone: molecular mechanisms of action in neuroprotection and neuroinflammation. Pharmaceuticals (Basel) 18(7):945. https:\/\/doi.org\/10.3390\/ph18070945","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"2150_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1742-2094-9-38","volume":"9","author":"Garrido-Gil","year":"2012","unstructured":"Garrido-Gil et al (2012) Involvement of PPAR-\u03b3 in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson\u2019s disease. J Neuroinflammation 9(1):38. https:\/\/doi.org\/10.1186\/1742-2094-9-38","journal-title":"J Neuroinflammation"},{"issue":"3","key":"2150_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/14737175.2017.1243469","volume":"17","author":"FS Giorgi","year":"2017","unstructured":"Giorgi FS, Guida M, Vergallo A, Bonuccelli U, Zaccara G (2017) Treatment of epilepsy in patients with Alzheimer\u2019s disease. Expert Rev Neurother 17(3):309\u2013318. https:\/\/doi.org\/10.1080\/14737175.2017.1243469","journal-title":"Expert Rev Neurother"},{"key":"2150_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.570711","volume":"11","author":"KL Hanslik","year":"2020","unstructured":"Hanslik KL, Ulland TK (2020) The role of microglia and the Nlrp3 inflammasome in Alzheimer\u2019s disease. Front Neurol 11:570711. https:\/\/doi.org\/10.3389\/fneur.2020.570711","journal-title":"Front Neurol"},{"key":"2150_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchemneu.2021.101960","volume":"114","author":"X-y Huang","year":"2021","unstructured":"Huang X-y et al (2021) Everolimus inhibits PI3K\/Akt\/mTOR and NF-kB\/IL-6 signaling and protects seizure-induced brain injury in rats. J Chem Neuroanat 114:101960. https:\/\/doi.org\/10.1016\/j.jchemneu.2021.101960","journal-title":"J Chem Neuroanat"},{"key":"2150_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.919973","volume":"13","author":"SA Ihim","year":"2022","unstructured":"Ihim SA, Abubakar SD, Zian Z, Sasaki T, Saffarioun M, Maleknia S, Azizi G (2022) Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: biological role in induction, regulation, and treatment. Front Immunol 13:919973. https:\/\/doi.org\/10.3389\/fimmu.2022.919973","journal-title":"Front Immunol"},{"key":"2150_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2010.00019","volume":"2","author":"BP Imbimbo","year":"2010","unstructured":"Imbimbo BP, Solfrizzi V, Panza F (2010) Are NSAIDs useful to treat Alzheimer\u2019s disease or mild cognitive impairment? Front Aging Neurosci 2:1517. https:\/\/doi.org\/10.3389\/fnagi.2010.00019","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"2150_CR26","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1159\/000537794","volume":"33","author":"S Kalakh","year":"2024","unstructured":"Kalakh S, Mouihate A (2024) The effects of neuroactive steroids on myelin in health and disease. Med Princ Pract 33(3):198\u2013214. https:\/\/doi.org\/10.1159\/000537794","journal-title":"Med Princ Pract"},{"issue":"1","key":"2150_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.5472\/marumj.1629028","volume":"38","author":"T Karamahmuto\u011flu","year":"2025","unstructured":"Karamahmuto\u011flu T (2025) Evaluation of isolated and combined effects of riluzole and sodium valproate in genetic absence epilepsy rats. Marmara Med J 38(1):68\u201375. https:\/\/doi.org\/10.5472\/marumj.1629028","journal-title":"Marmara Med J"},{"key":"2150_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.neuint.2011.11.015","volume":"60","author":"HN Kim","year":"2012","unstructured":"Kim HN, Lee SJ, Koh JY (2012) The neurosteroids, allopregnanolone and progesterone, induce autophagy in cultured astrocytes. Neurochem Int 60:125\u2013133. https:\/\/doi.org\/10.1016\/j.neuint.2011.11.015","journal-title":"Neurochem Int"},{"key":"2150_CR29","doi-asserted-by":"publisher","unstructured":"Kumpaty S, Hoeffel J, McDade Kt, & Sacks N (2024) United States-South Africa international collaboration leading to a unique summer research experience of STEM Scholars: Lessons from a Pilot Initiative. Paper presented at the ASME international mechanical engineering congress and exposition. https:\/\/doi.org\/10.1115\/IMECE2024-141836","DOI":"10.1115\/IMECE2024-141836"},{"key":"2150_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00210-024-03253-x","volume":"5","author":"SK Kushawaha","year":"2024","unstructured":"Kushawaha SK, Ashawat MS, Baldi A (2024) Auranofin-loaded PLGA nanoparticles alleviate cognitive deficit induced by STZ in rats model: modulation of oxidative stress, neuroinflammatory markers, and neurotransmitters. Naunyn Schmiedebergs Arch Pharmacol 5:1\u201317. https:\/\/doi.org\/10.1007\/s00210-024-03253-x","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2150_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-025-01805-y","author":"SK Kushawaha","year":"2025","unstructured":"Kushawaha SK, Kumar H, Chauhan C, Chaudhary S, Ashawat MS (2025) Repurposing Saroglitazar for neurodegenerative disorders: insight into molecular signalling pathways and neuroprotective modulations. Inflammopharmacology. https:\/\/doi.org\/10.1007\/s10787-025-01805-y","journal-title":"Inflammopharmacology"},{"issue":"8","key":"2150_CR32","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s40265-022-01724-0","volume":"82","author":"YN Lamb","year":"2022","unstructured":"Lamb YN (2022) Ganaxolone: first approval. Drugs 82(8):933\u2013940. https:\/\/doi.org\/10.1007\/s40265-022-01724-0","journal-title":"Drugs"},{"issue":"11","key":"2150_CR33","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1080\/14737175.2021.1904895","volume":"21","author":"S Lattanzi","year":"2021","unstructured":"Lattanzi S, Riva A, Striano P (2021) Ganaxolone treatment for epilepsy patients: from pharmacology to place in therapy. Expert Rev Neurother 21(11):1317\u20131332. https:\/\/doi.org\/10.1080\/14737175.2021.1904895","journal-title":"Expert Rev Neurother"},{"issue":"9","key":"2150_CR34","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/j.1528-1157.2000.tb00324.x","volume":"41","author":"K Laxer","year":"2000","unstructured":"Laxer K et al (2000) Assessment of ganaxolone\u2019s anticonvulsant activity using a randomized, double\u2010blind, presurgical trial design. Epilepsia 41(9):1187\u20131194. https:\/\/doi.org\/10.1111\/j.1528-1157.2000.tb00324.x","journal-title":"Epilepsia"},{"key":"2150_CR35","unstructured":"Lejri I (2016) Characterization of novel mitochondrial modulators for the development of neuroprotective strategies. Universit\u00e9 de Strasbourg; Universit\u00e4t Basel"},{"issue":"4","key":"2150_CR36","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2174\/1567205011310040008","volume":"10","author":"L Li","year":"2013","unstructured":"Li L, Zhang S, Zhang X, Li T, Tang Y, Liu H et al (2013) Autophagy enhancer carbamazepine alleviates memory deficits and cerebral amyloid-\u03b2 pathology in a mouse model of Alzheimer\u2019s disease. Curr Alzheimer Res 10(4):433\u2013441. https:\/\/doi.org\/10.2174\/1567205011310040008","journal-title":"Curr Alzheimer Res"},{"issue":"4","key":"2150_CR37","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3892\/etm.2014.1858","volume":"8","author":"X Li","year":"2014","unstructured":"Li X, Zhang J, Chai S, Wang X (2014) Progesterone alleviates hypoxic-ischemic brain injury via the Akt\/GSK-3\u03b2 signaling pathway. Exp Ther Med 8(4):1241\u20131246. https:\/\/doi.org\/10.3892\/etm.2014.1858","journal-title":"Exp Ther Med"},{"issue":"7","key":"2150_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/1750-3841.70235","volume":"90","author":"D Li","year":"2025","unstructured":"Li D, Lu W, Wang R, Ma Y (2025) MFG-E8 in microglial regulation: a review of basic research in the central nervous system. J Food Sci 90(7):e70235. https:\/\/doi.org\/10.1111\/1750-3841.70235","journal-title":"J Food Sci"},{"issue":"9","key":"2150_CR39","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/modpathol.2016.97","volume":"29","author":"SY Liu","year":"2016","unstructured":"Liu SY et al (2016) Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase\/RAS signaling pathways and provides insights into intratumoral heterogeneity. Mod Pathol 29(9):1012\u20131027. https:\/\/doi.org\/10.1038\/modpathol.2016.97","journal-title":"Mod Pathol"},{"issue":"2","key":"2150_CR40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/WCO.0000000000001356","volume":"38","author":"N Lonkar","year":"2025","unstructured":"Lonkar N, Latz E, McManus RM (2025) Neuroinflammation and immunometabolism in neurodegenerative diseases. Curr Opin Neurol 38(2):163\u2013171. https:\/\/doi.org\/10.1097\/WCO.0000000000001356","journal-title":"Curr Opin Neurol"},{"key":"2150_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsi.2025.110597","author":"Lu","year":"2025","unstructured":"Lu et al (2025) A novel toll-like receptor in hyriopsis cumingii responds to aeromonas veronii GL1 infection by the MyD88 signaling pathway. Fish Shellfish Immunol. https:\/\/doi.org\/10.1016\/j.fsi.2025.110597","journal-title":"Fish Shellfish Immunol"},{"key":"2150_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-025-05359-z","author":"D Mafra","year":"2025","unstructured":"Mafra D, Alvarenga L, de Velasco PC, de Mattos Manh\u00e3es L, de Santana e Santana LD, Borges NA (2025) The gut microbiota-NLRP3 inflammasome connection: current evidence and perspectives for non-communicable diseases. Mol Cell Biochem. https:\/\/doi.org\/10.1007\/s11010-025-05359-z","journal-title":"Mol Cell Biochem"},{"key":"2150_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-04918-1","author":"R Maurya","year":"2025","unstructured":"Maurya R, Sharma A, Naqvi S (2025) Decoding NLRP3 inflammasome activation in Alzheimer\u2019s disease: a focus on receptor dynamics. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-025-04918-1","journal-title":"Mol Neurobiol"},{"key":"2150_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00113","volume":"8","author":"M Medina","year":"2014","unstructured":"Medina M, Avila J (2014) The role of extracellular Tau in the spreading of neurofibrillary pathology. Front Cell Neurosci 8:113. https:\/\/doi.org\/10.3389\/fncel.2014.00113","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"2150_CR45","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1007\/s12035-024-04457-1","volume":"62","author":"J Miao","year":"2025","unstructured":"Miao J, Zhang Y, Su C, Zheng Q, Guo J (2025) Insulin-like growth factor signaling in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol Neurobiol 62(3):3195\u20133225. https:\/\/doi.org\/10.1007\/s12035-024-04457-1","journal-title":"Mol Neurobiol"},{"issue":"3","key":"2150_CR46","doi-asserted-by":"publisher","first-page":"039","DOI":"10.7324\/JAPS.2024.194605","volume":"15","author":"S Mishra","year":"2025","unstructured":"Mishra S, Pattanaik S, Sahoo S, Prusty SK, Sahu PK, Das D (2025) New insights into repurposing of renin-angiotensin system inhibitors against Alzheimer\u2019s disease. J Appl Pharm Sci 15(3):039\u2013049. https:\/\/doi.org\/10.7324\/JAPS.2024.194605","journal-title":"J Appl Pharm Sci"},{"issue":"2","key":"2150_CR47","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R (2021) Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov 20(2):101\u2013124. https:\/\/doi.org\/10.1038\/s41573-020-0090-8","journal-title":"Nat Rev Drug Discov"},{"key":"2150_CR48","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S277457","author":"MD Molla","year":"2020","unstructured":"Molla MD, Akalu Y, Geto Z, Dagnew B, Ayelign B, Shibabaw T (2020) Role of caspase-1 in the pathogenesis of inflammation-associated chronic noncommunicable diseases. J Inflamm Res. https:\/\/doi.org\/10.2147\/JIR.S277457","journal-title":"J Inflamm Res"},{"issue":"2","key":"2150_CR49","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/cns.13195","volume":"26","author":"A Mouihate","year":"2020","unstructured":"Mouihate A, Kalakh S (2020) Ganaxolone enhances microglial clearance activity and promotes remyelination in focal demyelination in the corpus callosum of ovariectomized rats. CNS Neurosci Ther 26(2):240\u2013250. https:\/\/doi.org\/10.1111\/cns.13195","journal-title":"CNS Neurosci Ther"},{"key":"2150_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2025.1590002","volume":"19","author":"L M\u00fcller","year":"2025","unstructured":"M\u00fcller L, Di Benedetto S (2025) Bridging the brain and gut: neuroimmune mechanisms of neuroinflammation and therapeutic insights. Front Cell Neurosci 19:1590002. https:\/\/doi.org\/10.3389\/fncel.2025.1590002","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"2150_CR51","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3390\/futurepharmacol3040053","volume":"3","author":"K Nagori","year":"2023","unstructured":"Nagori K et al (2023) Unlocking the therapeutic potential of medicinal plants for Alzheimer\u2019s disease: preclinical to clinical trial insights. Future Pharmacol 3(4):877\u2013907. https:\/\/doi.org\/10.3390\/futurepharmacol3040053","journal-title":"Future Pharmacol"},{"issue":"1","key":"2150_CR52","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.nurt.2006.11.003","volume":"4","author":"V Nohria","year":"2007","unstructured":"Nohria V, Giller E (2007) Ganaxolone. Neurotherapeutics 4(1):102\u2013105. https:\/\/doi.org\/10.1016\/j.nurt.2006.11.003","journal-title":"Neurotherapeutics"},{"issue":"5","key":"2150_CR53","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1007\/s12035-023-03217-x","volume":"60","author":"X Peng","year":"2023","unstructured":"Peng X, Guo H, Zhang X, Yang Z, Ruganzu JB, Yang Z, Yang W (2023) TREM2 inhibits tau hyperphosphorylation and neuronal apoptosis via the PI3K\/Akt\/GSK-3\u03b2 signaling pathway in vivo and in vitro. Mol Neurobiol 60(5):2470\u20132485. https:\/\/doi.org\/10.1007\/s12035-023-03217-x","journal-title":"Mol Neurobiol"},{"issue":"9","key":"2150_CR54","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s40263-023-01027-2","volume":"37","author":"E Perucca","year":"2023","unstructured":"Perucca E, Bialer M, White HS (2023) New GABA-targeting therapies for the treatment of seizures and epilepsy: I. Role of GABA as a modulator of seizure activity and recently approved medications acting on the GABA system. CNS Drugs 37(9):755\u2013779. https:\/\/doi.org\/10.1007\/s40263-023-01027-2","journal-title":"CNS Drugs"},{"issue":"1","key":"2150_CR55","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/14728214.2022.2059464","volume":"27","author":"AW Pong","year":"2022","unstructured":"Pong AW, Ross J, Tyrlikova I, Giermek AJ, Kohli MP, Khan YA, Klein P (2022) Epilepsy: expert opinion on emerging drugs in phase 2\/3 clinical trials. Expert Opin Emerg Drugs 27(1):75\u201390. https:\/\/doi.org\/10.1080\/14728214.2022.2059464","journal-title":"Expert Opin Emerg Drugs"},{"key":"2150_CR56","unstructured":"Prince M, Wimo, A, Guerchet M, Ali, GC, Wu, Y-T, & Prina, M (2015) World Alzheimer report 2015. The global impact of dementia: an analysis of prevalence, incidence, cost and trends. Alzheimer\u2019s Disease International"},{"key":"2150_CR57","doi-asserted-by":"crossref","unstructured":"Rabieipoor S (2024) Study on effects of metformin and transplantation of NPCs separately and in combination on restores cognitive dysfunction and histopathological deficits in mouse model of sporadic Alzheimer\u2019s disease","DOI":"10.1016\/j.heliyon.2023.e17873"},{"issue":"1","key":"2150_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.70072","volume":"13","author":"M Rahimi-Tesiye","year":"2025","unstructured":"Rahimi-Tesiye M, Rajabi-Maham H, Azizi V, Hosseini A (2025) The anticonvulsant effect of nonsteroidal anti-inflammatory drug, fenoprofen, in pentylenetetrazole-induced epileptic rats: behavioral, histological, and biochemical evidence. Pharmacol Res Perspect 13(1):e70072. https:\/\/doi.org\/10.1002\/prp2.70072","journal-title":"Pharmacol Res Perspect"},{"issue":"3","key":"2150_CR59","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1358\/dof.2004.029.03.793135","volume":"29","author":"DS Reddy","year":"2004","unstructured":"Reddy DS, Woodward R (2004) Ganaxolone: a prospective overview. Drugs Future 29(3):227\u2013242. https:\/\/doi.org\/10.1358\/dof.2004.029.03.793135","journal-title":"Drugs Future"},{"key":"2150_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00400","volume":"9","author":"C Rotermund","year":"2018","unstructured":"Rotermund C, Machetanz G, Fitzgerald JC (2018) The therapeutic potential of metformin in neurodegenerative diseases. Front Endocrinol 9:400. https:\/\/doi.org\/10.3389\/fendo.2018.00400","journal-title":"Front Endocrinol"},{"issue":"4","key":"2150_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/biom15040502","volume":"15","author":"A S\u0103lcudean","year":"2025","unstructured":"S\u0103lcudean A, Bodo CR, Popovici RA, Cozma MM, P\u0103curar M, Cr\u0103ciun RE, Cimpian DM (2025) Neuroinflammation a crucial factor in the pathophysiology of depression: a comprehensive review. Biomolecules 15(4):502. https:\/\/doi.org\/10.3390\/biom15040502","journal-title":"Biomolecules"},{"issue":"9","key":"2150_CR62","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1172\/JCI90606","volume":"127","author":"H Sarlus","year":"2017","unstructured":"Sarlus H, Heneka MT (2017) Microglia in Alzheimer\u2019s disease. J Clin Invest 127(9):3240\u20133249. https:\/\/doi.org\/10.1172\/JCI90606","journal-title":"J Clin Invest"},{"issue":"22","key":"2150_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212155","volume":"25","author":"M Scuto","year":"2024","unstructured":"Scuto M, Majz\u00fanov\u00e1 M, Torcitto G, Antonuzzo S, Rampulla F, Di Fatta E, Trovato Salinaro A (2024) Functional food nutrients, redox resilience signaling and neurosteroids for brain health. Int J Mol Sci 25(22):12155. https:\/\/doi.org\/10.3390\/ijms252212155","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2150_CR64","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8(6):595\u2013608. https:\/\/doi.org\/10.15252\/emmm.201606210","journal-title":"EMBO Mol Med"},{"issue":"1","key":"2150_CR65","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s10753-022-01730-0","volume":"46","author":"B Sharma","year":"2023","unstructured":"Sharma B, Satija G, Madan A, Garg M, Alam MM, Shaquiquzzaman M, Iqubal A (2023) Role of NLRP3 inflammasome and its inhibitors as emerging therapeutic drug candidate for Alzheimer\u2019s disease: a review of mechanism of activation, regulation, and inhibition. Inflammation 46(1):56\u201387. https:\/\/doi.org\/10.1007\/s10753-022-01730-0","journal-title":"Inflammation"},{"issue":"4","key":"2150_CR66","doi-asserted-by":"publisher","first-page":"558","DOI":"10.15252\/emmm.201606210","volume":"58","author":"MR Sperling","year":"2017","unstructured":"Sperling MR, Klein P, Tsai J (2017) Randomized, double-blind, placebo-controlled phase 2 study of ganaxolone as add-on therapy in adults with uncontrolled partial onset seizures. Epilepsia 58(4):558\u2013564. https:\/\/doi.org\/10.15252\/emmm.201606210","journal-title":"Epilepsia"},{"key":"2150_CR67","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkaf043","author":"B Sun","year":"2025","unstructured":"Sun B, Zhang J, Li Z, Wang J, Zhao C, Xu X (2025) Role of damage-associated molecular patterns (DAMPs) in the pathogenesis and therapeutics of traumatic brain injury. Burns Trauma. https:\/\/doi.org\/10.1093\/burnst\/tkaf043","journal-title":"Burns Trauma"},{"key":"2150_CR68","doi-asserted-by":"publisher","DOI":"10.37349\/ent.2021.00008","volume":"1","author":"K Tariq","year":"2021","unstructured":"Tariq K, Luikart BW (2021) Striking a balance: PIP2 and PIP3 signaling in neuronal health and disease. Explor Neuroprotect Ther 1:86. https:\/\/doi.org\/10.37349\/ent.2021.00008","journal-title":"Explor Neuroprotect Ther"},{"key":"2150_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00417","volume":"11","author":"P Thomas","year":"2020","unstructured":"Thomas P, Pang Y (2020) Anti-apoptotic actions of allopregnanolone and ganaxolone mediated through membrane progesterone receptors (PAQRs) in neuronal cells. Front Endocrinol 11:417. https:\/\/doi.org\/10.3389\/fendo.2020.00417","journal-title":"Front Endocrinol"},{"key":"2150_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118066","volume":"257","author":"S Vazifehkhah","year":"2020","unstructured":"Vazifehkhah S, Ali MK, Babae JF, Hashemi P, Alireza MS, Nikbakht F (2020) Evaluation of the ameliorative effects of oral administration of metformin on epileptogenesis in the temporal lobe epilepsy model in rats. Life Sci 257:118066. https:\/\/doi.org\/10.1016\/j.lfs.2020.118066","journal-title":"Life Sci"},{"issue":"1","key":"2150_CR71","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/361721","volume":"2012","author":"V Vigneswara","year":"2012","unstructured":"Vigneswara V, Kundi S, Ahmed Z (2012) Receptor tyrosine kinases: molecular switches regulating CNS axon regeneration. J Signal Transduct 2012(1):361721. https:\/\/doi.org\/10.1155\/2012\/361721","journal-title":"J Signal Transduct"},{"key":"2150_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-025-01576-w","author":"WL Wu","year":"2025","unstructured":"Wu WL, Gong XX, Qin ZH, Wang Y (2025) Molecular mechanisms of excitotoxicity and their relevance to the pathogenesis of neurodegenerative diseases: an update. Acta Pharmacol Sin. https:\/\/doi.org\/10.1038\/s41401-025-01576-w","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"2150_CR73","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-021-02738-3","volume":"11","author":"M Zheng","year":"2021","unstructured":"Zheng M, Wang P (2021) Role of insulin receptor substance-1 modulating PI3K\/Akt insulin signaling pathway in Alzheimer\u2019s disease. 3 Biotech 11(4):179. https:\/\/doi.org\/10.1007\/s13205-021-02738-3","journal-title":"3 Biotech"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02150-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02150-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02150-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:02:42Z","timestamp":1773777762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02150-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2150"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02150-4","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}